Team:University College London/LabBook/Week6

From 2012.igem.org

(Difference between revisions)
(→6.3)
(→Thursday 19.7.12)
Line 147: Line 147:
'''Step 9 – Plating samples on Agar Plates:''' The table below indicates the chosen inoculation volume (two for each BioBrick) and the correct gel antibiotic concentration for all samples.
'''Step 9 – Plating samples on Agar Plates:''' The table below indicates the chosen inoculation volume (two for each BioBrick) and the correct gel antibiotic concentration for all samples.
 +
 +
{| class="wikitable"
 +
|-
 +
! colspan="2" |  Samples !! Volume Inoculated !! Antibiotic in Gel (ug/ml)
 +
|-
 +
| rowspan="8" |BioBrick ||rowspan="2" | BBa_J23119 || 10ul || rowspan="8" | Ampicillin(50ug/ml)
 +
|-
 +
| 90ul
 +
|-
 +
| rowspan="2" | BBa_I750016 || 10ul
 +
|-
 +
| 90ul
 +
|-
 +
| rowspan="2" | BBa_B0015  || 10ul
 +
|-
 +
| 90ul
 +
|-
 +
| rowspan="2" | BBa_B0034  || 10ul
 +
|-
 +
| 90ul
 +
|-
 +
| rowspan="2" | Control || Positive Positive (Contains BioBrick – one for each of the above)|| 36ul || No Antibiotic
 +
|-
 +
| Negative (No BioBrick)|| 36ul ||  1x Ampicillin(50ug/ml)
 +
|-
 +
|}
 +
 +
 +
== Friday 20.7.12 ==
 +
 +
'''Aim 1 - Results of Transformation Result:''' Table below indicates there was growth for all of our transformed cells, and that the controls worked. Also included is an image of each plate.
 +
 +
{| class="wikitable"
 +
|-
 +
! colspan="2" |  Samples !! Volume Inoculated !! Growth/ No Growth
 +
|-
 +
| rowspan="8" |BioBrick ||rowspan="2" | BBa_J23119 || 10ul || Growth
 +
|-
 +
| 90ul || Growth
 +
|-
 +
| rowspan="2" | BBa_I750016 || 10ul || Growth
 +
|-
 +
| 90ul || Growth
 +
|-
 +
| rowspan="2" | BBa_B0015  || 10ul || Growth
 +
|-
 +
| 90ul || Growth
 +
|-
 +
| rowspan="2" | BBa_B0034  || 10ul || Growth
 +
|-
 +
| 90ul || Growth
 +
|-
 +
| rowspan="2" | Control || Positive Positive (Contains BioBrick – one for each of the above)|| 36ul  || Growth
 +
|-
 +
| Negative (No BioBrick)|| 36ul  || No Growth
 +
|-
 +
|}
 +
<html>
<html>

Revision as of 11:28, 1 August 2012

Contents

Tuesday 17.7.12

Aim -Testing the competency of the Reinvigorated Cell Line (W3110): After our original attempt to generate competency of the W3100 cell line was inadequate, we undertook a reinvigoration of the W3100 cell line (Expt 5.2). Here we aim to test the competency of the reinvigorated cell line using the same protocol as used in Expt 5.3, by evaluating their growth after transformation with a plasmid of a known high concentration (297ng/ul).

Method

(LOGO) Transformation Protocol 2

Step 1 – Thawing Cells: Use the reinvigorated W3100 cell line created in Week 5 (Expt 5.2)

Step 3 – Addition of BioBrick: To one 2ml eppendorf, add 1ul of pTop plasmid, and to another add nothing – this will be a control.

Step 7 – Adding Broth: SOC media was used, as it is preferred for this protocol.

Step 8 - Incubation: The table below indicates the Ampicillin concentration of the Agar gels.

Samples Volume Innoculated Antibiotic in Gel (conc)
Plasmid pTOP 36ul Ampicillin (50ug/ml)
Control Positive (No Plasmid) 36ul No Antibiotic
Negative (No Plasid) 36ul Ampicillin (50ug/ml)


Wednesday (18.7.12)

Aim - Results from Transformation

Result: Table below indicates there was no growth for our cells, but that the controls worked. Also included is an image of each plate.

Samples Growth/No Growth
Plasmid pTOP No Growth
Control Positive (No Plasmid) Growth
Negative (No Plasid) No Growth


Wednesday (18.7.12)

Aim - Testing the transformation protocols: In light of the problems with cell competency, we decided to test whether the choice of protocol was contributing to the poor transformation results – especially as it would require another week to set up another cell line. We used a known competent cell line, and tested its competency against both of our cell lines, for Transformation Protocol 1 vs Transformation Protocol 2. Each sample was plated on an Ampicillin positive Agar and incubated overnight.

(LOGO) Transformation - Protocol 1

(LOGO) Transformation - Protocol 2

Step ?: The table below describes the plates necessary for this investigation, each of which shoud carry Ampicillin antibiotic at a concentration of 50ug/ml.

Plates
Protocol 1 W3100 – Original
W3100 – Reinvigorated
W3100 – Known Competent
Protocol 2 W3100 – Original
W3100 – Reinvigorated
W3100 – Known Competent


Thursday 19.7.12

Aim - Results from Transformation of pTop

Results: Table below indicates there was significant growth from the Original W3100 cells, but not from other cell lines.


Plates Colony Formation
Protocol 1 W3100 – Original Yes
W3100 – Reinvigorated No
W3100 – Known Competent No
Protocol 2 W3100 – Original Yes
W3100 – Reinvigorated No
W3100 – Known Competent No

Conclusion: The Original Cell line appears to be competent for both Protocols, while our reinvigorated cell line does not appear to be competent with either. The cells known to be competent showed no growth, for reasons that are unclear. For our Original W3100 cell line, there was greater colony formation with Protocol 1 than with Protocol 2, so we shall proceed with this protocol. It is likely that the failure of our transformations is due to the switch to protocol 2, and the use of too little BioBrick to transform our cells. The protocol recommends 1-2ul, but members around the lab generally use 5ul for transforming cells. We will take this approach and see if our transformations improve.

Thursday 19.7.12

Aim – Transformations: Expt 6.3 will be transforming our main Constitutive Promoter - BBa_J23119 – which is to be used in a number of modules. It will also aim to transform the Gas Vesicle Polycistronic Gene BBa_I750016, which is required for the production of gas vesicles. Finally, it will also transform the Ribosome Binding Site BBa_B0034, which failed to transform in Expt 5.1, and the Double Termination BBa_B0015. Both of these are key to all modules. Method:

(LOGO) Transformation Protocol 1

Step 1 – Thawing Cells: Use W3100 cell line created in Week 2 (Expt 2.1)

Step 3 – Addition of BioBrick: To each 2ml eppendorf, add 1ul of the following BioBricks. Note: we have changed the protocol for our positive control. Previously it contained no BioBrick, but it has been recommended to us that we transform our positive control such that there is one for each BioBrick – this will tell us if the BioBrick has in any way affected cell viability. This will be used from this point onwards. Include an extra tube as a negative control, with no BioBrick added

Function Module
BioBrick BBa_J23119 Constitutive Promoter Degradation/

Salt Tolerance/ Containment

BBa_I750016 Gas Vesicle Polycistronic Gene Buoyancy
BBa_B0015 Double Terminator All
BBa_B0034 Ribosome Binding Site (RBS) All
Control (No BioBricks)

Step 9 – Plating samples on Agar Plates: The table below indicates the chosen inoculation volume (two for each BioBrick) and the correct gel antibiotic concentration for all samples.

Samples Volume Inoculated Antibiotic in Gel (ug/ml)
BioBrick BBa_J23119 10ul Ampicillin(50ug/ml)
90ul
BBa_I750016 10ul
90ul
BBa_B0015 10ul
90ul
BBa_B0034 10ul
90ul
Control Positive Positive (Contains BioBrick – one for each of the above) 36ul No Antibiotic
Negative (No BioBrick) 36ul 1x Ampicillin(50ug/ml)


Friday 20.7.12

Aim 1 - Results of Transformation Result: Table below indicates there was growth for all of our transformed cells, and that the controls worked. Also included is an image of each plate.

Samples Volume Inoculated Growth/ No Growth
BioBrick BBa_J23119 10ul Growth
90ul Growth
BBa_I750016 10ul Growth
90ul Growth
BBa_B0015 10ul Growth
90ul Growth
BBa_B0034 10ul Growth
90ul Growth
Control Positive Positive (Contains BioBrick – one for each of the above) 36ul Growth
Negative (No BioBrick) 36ul No Growth


Retrieved from "http://2012.igem.org/Team:University_College_London/LabBook/Week6"